HbA1c Testing Market, By Type (Laboratory-based Testing, Point-of-Care Testing), Technology (Immunoassays, Chromatography, Boronate Affinity Chromatography, HPLC), End-use (Hospital, Diagnostic Labs, Homecare) -Forecast (2024 - 2032)

PUBLISHED: May 24, 2024

PAGES: 230 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The HbA1c Testing Market size will expand at 8.6% rate during 2024-2032, driven by the rising prevalence of diabetes. According to Internation Diabetes Federation, in 2021, 537 million adults, or approximately 1 in 10, were living with diabetes. This number is projected to increase significantly, reaching 643 million by 2030 and 783 million by 2045. With increasing rate of diabetes globally, driven by factors such as sedentary lifestyles, unhealthy diets, and aging populations, the demand for effective diabetes management tools is surging. HbA1c testing, which measures long-term blood glucose levels, is crucial for monitoring and managing diabetes and preventing its complications.

As countries invest in upgrading and expanding their healthcare facilities, the accessibility and quality of diabetes diagnostic services are improving. The increased availability of state-of-the-art equipment and improved healthcare delivery systems contribute to more efficient and widespread HbA1c testing.

The HbA1c testing industry is classified based on type, technology, end-use, and region.

The laboratory-based testing segment will grow rapidly through 2032, as they are considered the gold standard for HbA1c measurement due to their high accuracy and reliability. These tests utilize advanced techniques such as high-performance liquid chromatography (HPLC) and immunoassays to provide precise results, essential for effective diabetes management. The robustness of laboratory-based testing, along with its ability to handle high patient volumes and provide comprehensive diagnostic information, makes it a preferred choice for healthcare facilities.

The homecare segment will witness decent growth through 2032. With the increasing adoption of home monitoring devices, patients with diabetes are increasingly managing their HbA1c levels at home. The convenience of homecare testing devices allows individuals to track their glucose levels regularly, which is crucial for effective diabetes management. Innovations in home testing technologies, such as user-friendly glucose meters and HbA1c home testing kits, are making it easier for patients to perform tests and obtain reliable results without frequent visits to healthcare facilities.

Europe HbA1c testing industry size will expand at a steady pace through 2032, driven by the region's well-established healthcare infrastructure, coupled with high awareness levels about diabetes and its management. European countries are investing in advanced diagnostic technologies and enhancing healthcare services to improve diabetes care. Additionally, government initiatives and medical policies aimed at increasing diabetes screening and early detection are contributing to the market expansion.

Product Code: 9631

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360°synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of diabetes
  - 3.2.1.2 Technological advancement
  - 3.2.1.3 Development of novel testing methodologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of devices
  - 3.2.2.2 Stringent regulatory policies
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Laboratory-based testing
5.3 Point-of-care (POC) testing

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Immunoassays
6.3 Chromatography
6.4 Enzymatic assays
6.5 Boronate affinity chromatography
6.6 High-performance liquid chromatography
6.7 Other technologies

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals & clinics
7.3 Diagnostic laboratories
7.4 Homecare settings
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa